Note*: This report requires 7-10 business days to complete.
DelveInsight’s Candidiasis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Candidiasis forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Candidiasis till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Candidiasis market.
• Identifying patient populations in the global “Candidiasismarket to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Candidiasis therapeutics in each of the markets covered.
• To understand the future market competition in the global Candidiasis therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Candidiasis for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
'
Table of Contents
• Candidiasis overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Candidiasis Market
• Global Epidemiology of Candidiasis Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Candidiasis Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Candidiasis (2013-2023)
• Table 7: Candidiasis Global Market (USD Millions), (2013-2015)
• Table 8: Candidiasis Global Market (USD Millions), (2016-2023)
• Table 9: Candidiasis US Market (USD Millions), (2013-2015)
• Table 10: Candidiasis US Market (USD Millions), (2016-2023)
• Table 11: Candidiasis Germany Market (USD Millions), (2013-2015)
• Table 12: Candidiasis Germany Market (USD Millions), (2016-2023)
• Table 13: Candidiasis United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Candidiasis United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Candidiasis France Market (USD Millions), (2013-2015)
• Table 16: Candidiasis France Market (USD Millions), (2016-2023)
• Table 17: Candidiasis Italy Market (USD Millions), (2013-2015)
• Table 18: Candidiasis Italy Market (USD Millions), (2016-2023)
• Table 19: Candidiasis Spain Market (USD Millions), (2013-2015)
• Table 20: Candidiasis Spain Market (USD Millions), (2016-2023)
• Table 21: Candidiasis Japan Market (USD Millions), (2013-2015)
• Table 22: Candidiasis Japan Market (USD Millions), (2016-2023)
• Table 23: Candidiasis ROW Market (USD Millions), (2013-2015)
• Table 24: Candidiasis ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Candidiasis Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Candidiasis (2013-2023)
• Figure 3: Candidiasis Global Market (USD Millions), (2013-2015)
• Figure 4: Candidiasis Global Market (USD Millions), (2016-2023)
• Figure 5: Candidiasis US Market (USD Millions), (2013-2015)
• Figure 6: Candidiasis US Market (USD Millions), (2016-2023)
• Figure 7: Candidiasis Germany Market (USD Millions), (2013-2015)
• Figure 8: Candidiasis Germany Market (USD Millions), (2016-2023)
• Figure 9: Candidiasis United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Candidiasis United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Candidiasis France Market (USD Millions), (2013-2015)
• Figure 12: Candidiasis France Market (USD Millions), (2016-2023)
• Figure 13: Candidiasis Italy Market (USD Millions), (2013-2015)
• Figure 14: Candidiasis Italy Market (USD Millions), (2016-2023)
• Figure 15: Candidiasis Spain Market (USD Millions), (2013-2015)
• Figure 16: Candidiasis Spain Market (USD Millions), (2016-2023)
• Figure 17: Candidiasis Japan Market (USD Millions), (2013-2015)
• Figure 18: Candidiasis Japan Market (USD Millions), (2015-2023)
• Figure 19: Candidiasis ROW Market (USD Millions), (2013-2015)
• Figure 20: Candidiasis ROW Market (USD Millions), (2016-2023)
• Aureogen Biosciences Inc.
• Cellceutix Corporation
• Eisai Co. Ltd.
• GlaxoSmithKline Plc
• iCo Therapeutics Inc.
• Nanomerics Ltd
• Novabiotics Limited
• Onxeo SA
• Panacela Labs Inc.
• Scynexis Inc.
• Sealife PHARMA GMBH
• Sequella Inc.
• Viamet Pharmaceuticals Inc.
• Wellstat Vaccines LLC
